CAPSID BIOTECHNOLOGY LTD

What CAPSID BIOTECHNOLOGY LTD does

Capsid Biotechnology Ltd is a privately held, for-profit UK life science tools supplier founded in 2024 and headquartered in Waltham Abbey. The company supplies life science reagents, viral vector platforms, and custom screening tools targeted at drug discovery researchers and research organizations. Its offering spans three product categories: consumable research reagents, viral vector systems positioned for gene delivery research, and bespoke screening services intended to support therapeutic discovery workflows. The combination suggests a research-tools catalogue plus a custom-services arm rather than a single-product or platform-pure model.

No further information is disclosed in the supplied source set on the company's technology architecture, proprietary components, IP position, pricing model, customer segments, go-to-market motion, or competitive positioning. The firm's own website returned only a verification/loader page with no substantive operational, technical, or commercial content. There are no disclosed funding rounds, headcount figures, customer logos, partnerships, leadership bios, regulatory milestones, or revenue metrics.

Because the input provides almost no primary-source operational detail, conclusions here are necessarily limited to what the firmographic profile and short description state. The investment-relevant baseline is: an early-stage, privately held UK life sciences tools supplier with a multi-product offering and no currently observable commercial track record, customer base, or capital-raise history in the available data.

Name

CAPSID BIOTECHNOLOGY LTD

Website

https://capsidbio.co.uk

Company type

Private

Founded year

2024

Short description

Capsid Biotechnology Ltd, a UK-based life science tools supplier founded in 2024 in Waltham Abbey, provides research reagents, viral vector platforms, and custom screening services to drug discovery researchers and research laboratories.

Ownership category

akta.pro rank

Product category

Life Science Reagents

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream) (HLAAACAN), Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Life science reagents
• Viral vector platforms
• Drug discovery tools
• Custom screening assays
• Biotechnology research supplies

Headquarters

HQ city

Waltham Abbey

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D

Core offering

Capsid Biotechnology supplies life science reagents, viral vector platforms, and custom screening tools for drug discovery and research applications. The company provides tangible biological reagents and bespoke screening products that researchers and drug discovery teams procure for laboratory and experimental use.

Differentiator

Problem solved

Functional benefit

Products and services

• Life science reagents Biological reagents supplied by Capsid Biotechnology for use in drug discovery and laboratory research workflows by biotech and pharma research teams.
• Viral vector platforms Viral vector platforms supplied by Capsid Biotechnology to support research applications in drug discovery and laboratory studies, intended for biotech and pharma research customers.
• Custom screening tools Bespoke screening tools designed and supplied by Capsid Biotechnology for drug discovery and research use, allowing research teams to obtain tailored screening capabilities for specific experimental workflows.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Direct peers

• GenScript: Provides gene synthesis, viral vector services (e.g., AAV, lentivirus), and a broad catalog of life science reagents. Overlaps with Capsid on viral vector platforms and custom screening/research tools.
• VectorBuilder: Global supplier of custom viral vectors (AAV, lentivirus, adenovirus) and molecular biology reagents. Directly comparable product offering for viral vector platforms and custom cloning/screening tools used in drug discovery.
• Oxford Biomedica: UK-based leading viral vector CDMO specializing in lentiviral and AAV platforms for gene and cell therapy. Direct competitor in viral vector manufacturing and a comparable UK-headquartered supplier of vector-related tools and services.
• Aldevron: Supplies high-quality plasmid DNA, mRNA, and recombinant proteins used in gene therapy and vaccine development. Comparable as a specialist supplier of biological raw materials and reagents for advanced therapy developers.

Broad incumbents

• Cytiva: Major life science tools provider offering viral vector production platforms, reagents, and bioprocess services. A broad incumbent that overlaps with Capsid's reagents and viral vector platform offerings across a much larger portfolio.
• Charles River Laboratories: Global CRO/CDMO with significant viral vector manufacturing (Cell & Gene Therapy) and discovery screening services. Comparable across both the viral vector and custom drug discovery screening tool lines of the business.
• Thermo Fisher Scientific: Largest global supplier of life science reagents, lab instruments, and viral vector/production services (via Brammer Bio and Patheon acquisitions). A broad incumbent competitor across reagents and vector platforms.
• Bio-Techne: Supplies life science reagents, proteins, antibodies, and assay kits used in drug discovery research. Directly comparable on the reagents and assay/screening tools side of Capsid's offering.

Regional players

• Cell and Gene Therapy Catapult: UK-based organization operating manufacturing and process development facilities for viral vectors and cell/gene therapies. Comparable as a UK ecosystem participant supporting vector process development, though structured as a non-profit Catapult rather than a commercial supplier.

Emerging players

• SBI System Biosciences: Supplies viral vectors (lentivirus, AAV), gene delivery reagents, and custom research tools. Comparable niche/specialty competitor in the same viral vector and drug discovery reagent space.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAPSID BIOTECHNOLOGY LTD